Search results for "L. Bueno. Mechanisms involved in bacterial pathogen-induced intestinal mucosal barrier disruption: Therapeutic interest of mecha"

Poster published at the 39th annual paediatric Belgium society congress, Brussels, March 2011 (Poster publication)
As usual Noventure is participating at CPhI Worldwide, this year in Frankfurt. We would like to take this opportunity to hold face to face meetings with you, to discuss current and future opportunities and possible ways of collaboration between our companies.
EPA3G® is a food supplement:
Presented as a poster in the congress “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007.
Presented as a poster in the congress “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007.
We are pleased to inform you about our first #webinar sessions❗ On October 30th we talked about #UTIPROPLUS and its use in uncomplicated #UTIs.  Some KOLs presented their experiences with the product and spoke about the latest scientific updates on it and some partners shared the best practices and their experiences with Utipro® Plus across Europe. 
NOVENTURE will be present at Gastro Update Europe 2019, in Budapest, June 14 – 15, 2019. Visit us at our stand to learn about Gelsectan, our medical device for IBS-D.  
Noventure will attend the EAU 2023 to be held in Milan, 10-13 March 2023.  Arrange a meeting with us to learn more about our products and license availability in the different countries. Meet us at our Stand! Contact us: https://noventure.com/contact-us
Noventure will attend the EWMA 2023 to be held in Milan, 3-5 May 2023.  Arrange a meeting with us to learn more about our products and license availability in the different countries. Meet us at our Stand! Contact us: https://noventure.com/contact-us